Surflay Nanotec Company
Surflay Nanotec GmbH
Founded in 2008 by Dr. habil. Lars Dähne ● An interdisciplinary team of 13 scientists, engineers and technicians ● Located in the Berlin-Adlershof Technology Park, Surflay has access to technology / analytical techniques of numerous neighbour companies
Following the development of the Layer-by-layer encapsulation at Max Planck Institute of Colloids and Interfaces, five Max Planck scientists founded the start-up company Capsulution in 2001. The main focus of this startup was the encapsulation and delayed, or triggered, release of active pharmaceutical ingredients. In parallel, under the direction of the chemist Dr. Lars Dähne, successful research was ongoing on the application of LbL technology in non-pharmaceutical fields.
The increase in the succcess and importance of non-pharmaceutical applications eventually led to the starting of the spin-off company Surflay Nanotec GmbH in 2008 by Dr. Lars Dähne. Four employees of Capsulution joined the company shortly afterwards.
Through development of numerous innovative applications, Surflay has continued to grow and can now boast a team of 12 interdisciplinary scientists.
With modern equipment, excellent networking possibilities and a prime location in technology park Berlin-Adlershof, Surflay is at the cutting edge of polymer and surface science as well as microsensors. In the last 10 years, the company has helped academic and industrial partners develop highly valuable technologies and products – always rapidly and with a passion for science.
Dr. habil. Lars Dähne
Chief Executive Officer
Degree in Chemistry, Post-Doctorate in Organic Dye Chemistry, Habilitation Physical Chemistry
Dipl.-Ing. Götz Dähne
Technical Product Manager
Degree in Mechanical Engineering
Dr. Gabriella Egri
Degree in Biotechnology. Post-Doctorate in Organic Chemistry
M.Sc. Dennis Kaden
Degree in Pharmaceutical and Chemical Engineering
Dr. Aline Debrassi Smaczniak
MSc. in Pharmaceutical sciences, PhD in Surface Chemistry
Dr. Wei Wan
Degree in Chemistry, PhD in Organic Synthesis
Several active substances/medicines have to be released continuously over a long period of time or have to be delivered specifically to the site of action. This is necessary in order to achieve the best possible effect or to reduce possible side effects. Surflay develops drug delivery systems. We are also engaged in the coating of medical devices (e.g. stents).see our projects ...
Water is a valuable commodity, especially in times of drought and in areas with low water resources. In addition, the manufacturing industry in many industries requires thousands of cubic meters of fresh water, which must then be purified again. We develop novel membrane technologies together with our partners from the water industry.see our projects ...
Today, agriculture faces enormous challenges. On the one hand, farmers have to work as productively and economically as possible, and on the other hand, they are required to produce in an ecologically sustainable way. Surflay can support agriculture with innovative encapsulation techniques for pesticides, herbicides or fungicides.see our projects ...